Medco Downplays Competition From Health Plans’ In-House PBMs
Pharmacy benefit manager subsidiaries of large health insurers lack the scale and capability to provide the kinds of cost benefits and services offered by the big stand-alone PBMs, Medco Health Solutions Chairman David Snow maintains
You may also be interested in...
Schering-Plough says it will soon start providing monthly updates on prescription rates for its two cholesterol drugs Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) to help ease the minds of anxious investors
Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16
Medco will establish a presence in Medicare Part B with its $1.5 billion purchase of diabetes services provider PolyMedica